PA
CGON icon

Profund Advisors’s CG Oncology CGON Stock Holding History

Profund Advisors’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.08M Sell
30,688
-8,631
-22% -$489K 0.08% 193
2025
Q4 		$1.63M Buy
39,319
+25,568
+186% +$1.06M 0.05% 256
2025
Q3 		$554K Sell
13,751
-3,234
-19% -$94K 0.02% 479
2025
Q2 		$442K Buy
16,985
+1,841
+12% +$44.4K 0.02% 505
2025
Q1 		$371K Sell
15,144
-371
-2% -$10.4K 0.02% 577
2024
Q4 		$445K Sell
15,515
-342
-2% -$11.7K 0.02% 575
2024
Q3 		$598K Buy
15,857
+6,344
+67% +$222K 0.02% 457
2024
Q2 		$300K Buy
+9,513
New +$330K 0.01% 722

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM